Search research articles
Contact Us
Filters
Showing results (161-170 of 229) with videos related to
Page
of 23
Sort By:
Wiener Klinische Wochenschrift
|
January 21, 1983
[Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy]
R Lenzhofer, B Schneeweiss, H Rameis, et al.
Acta Radiologica. Supplementum
|
January 1, 1986
Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomas
K Heimberger, P Samec, H Binder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2001
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma
M De Santis, C Bokemeyer, A Becherer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer
C Dittrich, B Coudert, L Paz-Ares, et al.
The American Journal of Physiology
|
August 1, 1978
Increased in blood flow to ischemic myocardium caused by a new dopamine analog
J N Diana, B C Brenton, J P Long, et al.
Cancer Letters
|
May 1, 1997
Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-alpha in SK-BR-3 breast cancer cells
S H Flicker, S M Schneider, M Offterdinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
D Arnold, T Höhler, C Dittrich, et al.
Cardiology
|
October 22, 2009
Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes
Gad Cotter, Marco Metra, Beth Davison Weatherley, et al.
Geburtshilfe Und Frauenheilkunde
|
November 1, 1985
[Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]
H Salzer, E Gitsch, C Dittrich, et al.
Oncology Letters
|
September 12, 2012
Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer
M Baur, M Horvath, S Stättner, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 229) with videos related to
Sort By:
Page
of 23
Wiener Klinische Wochenschrift
|
January 21, 1983
[Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy]
R Lenzhofer, B Schneeweiss, H Rameis, et al.
Acta Radiologica. Supplementum
|
January 1, 1986
Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomas
K Heimberger, P Samec, H Binder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2001
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma
M De Santis, C Bokemeyer, A Becherer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer
C Dittrich, B Coudert, L Paz-Ares, et al.
The American Journal of Physiology
|
August 1, 1978
Increased in blood flow to ischemic myocardium caused by a new dopamine analog
J N Diana, B C Brenton, J P Long, et al.
Cancer Letters
|
May 1, 1997
Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-alpha in SK-BR-3 breast cancer cells
S H Flicker, S M Schneider, M Offterdinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
D Arnold, T Höhler, C Dittrich, et al.
Cardiology
|
October 22, 2009
Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes
Gad Cotter, Marco Metra, Beth Davison Weatherley, et al.
Geburtshilfe Und Frauenheilkunde
|
November 1, 1985
[Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]
H Salzer, E Gitsch, C Dittrich, et al.
Oncology Letters
|
September 12, 2012
Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer
M Baur, M Horvath, S Stättner, et al.
Page
of 23